Showing results (361-370 of 406) with videos related to
Sort By:
Pageof 41
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcomaM E Horowitz, T J Kinsella, L H Wexler, et al.Annals of Internal Medicine|October 1, 1984
Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomasP A Bunn, K A Foon, D C Ihde, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
Phase I and II study of high-dose ifosfamide, carboplatin, and etoposide with autologous bone marrow rescue in lymphomas and solid tumorsW H Wilson, V Jain, G Bryant, et al.Cancer Research|May 15, 1990
Phase I and immunomodulatory study of a muramyl peptide, muramyl tripeptide phosphatidylethanolamineW J Urba, L C Hartmann, D L Longo, et al.Cancer Research|December 1, 1993
Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinomaJ H Finke, A H Zea, J Stanley, et al.Cancer Research|April 15, 1991
Antitumor effects of interleukin 2 liposomes and anti-CD3-stimulated T-cells against murine MCA-38 hepatic metastasisC M Loeffler, J L Platt, P M Anderson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignanciesJ W Smith, W J Urba, B D Curti, et al.Blood|May 15, 1994
Inhibition of human B-cell lymphoma growth by CD40 stimulationS Funakoshi, D L Longo, M Beckwith, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: a high-grade lymphoma responsive to ProMACE-based combination chemotherapyD L Longo, P L Duffey, E S Jaffe, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|April 1, 1993
Immunomodulatory effects of interferon-gamma in patients with metastatic malignant melanomaW C Kopp, J W Smith, C H Ewel, et al.Pageof 41